OR
VC

OrbiMed

New York, United Statesorbimed.com

OrbiMed has 48 investments tracked. This firm invests across various stages and sectors. Analyze OrbiMed's investment portfolio, track their deal flow, and identify key decision-makers. Understand their investment criteria and strategic priorities. Monitor their investment performance and market impact.

237
Investments Tracked

About OrbiMed

OrbiMed is a venture capital firm based in New York, the United States. Brouky tracks 237 investments associated with the firm.

OrbiMed invests across Healthcare & Life Sciences; Software & Developer Tools; Consumer, Lifestyle & Services and Biotechnology. Coverage extends to 8 sectors in total. Participation spans Series A, Series B and Series C+ rounds.

OrbiMed is a healthcare-focused investment firm that invests globally across the spectrum of healthcare companies, from early-stage startups to large multinational corporations. They invest in biopharmaceuticals, medical devices, diagnostics, and healthcare services.

Investment Focus

Stage Focus
series-aseries-bseries-c-plus
Sectors
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & Servicesbiotechnologyoncologypharmaceutical-developmentbiotechpharmaceuticals

Investment Thesis

OrbiMed is a healthcare-focused investment firm that invests globally across the spectrum of healthcare companies, from early-stage startups to large multinational corporations. They invest in biopharmaceuticals, medical devices, diagnostics, and healthcare services.

OrbiMed Portfolio Companies

24 of 60 tracked holdings.

Azura OphthalmisIsrael
Aspen NeuroscienceUnited States
GarudaUnited States
Avstera TherapeuticsCanada
CytekUnited StatesSparrow PharmaceuticalsUnited States
Clover TherapeuticsChina
Sionna TherapeuticsUnited States
Terremoto BiosciencesUnited States
Odyssey TherapeuticsUnited States
MiroculusUnited States
Caris LifeUnited States
ACELYRINUnited StatesAzura OphthalmicsIsraelNFlection TherapeuticsUnited States
Electra TherapeuticsGermany
BeiGeneChinaSplienseIsraelAmolyt PharmaFranceYishengBioChinaGalectoDenmark
Chinook TherapeuticsCanada
MiaoshouChinaAdelaCanada
Portfolio outcomes
180 active12 acquired2 stalled4 defunct5.1% exit rate

Team

Sven Borho

Explore OrbiMed's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Software & Developer Tools